Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
News Release Digital Asset Direct

Modivcare Awarded ISO 27001 Security Certification

Modivcare

Modivcare Inc. (“Modivcare”) (Nasdaq: MODV), a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions focused on improving patient outcomes, today announced it has been awarded ISO 27001 certification for its non-emergency medical transportation division. ISO 27001 is an international information security management standard published by the International Organization for Standardization (ISO) – the world's largest developer of voluntary international standards – and the International Electrotechnical Commission (IEC). Unlike other certifications and compliance attestations that are much narrower in scope, ISO 27001 is a broad-spectrum certification that speaks to the health and robustness of an organization’s overall information security program. ISO 27001 sets out requirements for Modivcare’s information security management system to ensure the protection of sensitive data. The certification confirms that Modivcare operates a fundamentally sound, risk-focused professional security program based on an open security standard that has been tested for decades. Adhering to this standard enables Modivcare to manage the security of assets such as financial information, intellectual property, employee details, or information entrusted by third parties. “A company’s information security program sets the foundation for its ability to provide secure solutions, such as defending against and recovery from cyberattacks or preventing the loss of sensitive data,” said Modivcare Chief Information Officer, Walt Meffert. “This certification is significant because it tells our patients and customers that they can be confident their data is secure within our environment.” Modivcare’s non-emergency medical transportation (NEMT) services provide patients access to safe and reliable rides to health services. Working with local, community-based transportation providers, Modivcare is the largest broker of NEMT in the nation and brings more than 35 years of experience to its transportation providers and more than 75 million trips managed annually for 30 million patients across the United States. About Modivcare Modivcare Inc. (“Modivcare”) (Nasdaq: MODV) is a technology-enabled healthcare services company that provides a platform of integrated supportive care solutions for public and private payors and their patients. Our value-based solutions address the social determinants of health (SDoH), enable greater access to care, reduce costs, and improve outcomes. We are a leading provider of non-emergency medical transportation (NEMT), personal and home care, remote patient monitoring, medication management and meal delivery. Modivcare also holds a minority equity interest in CCHN Group Holdings, Inc. and its subsidiaries (“Matrix Medical Network”), which partners with leading health plans and providers nationally, delivering a broad array of assessment and care management services to individuals that improve health outcomes and health plan financial performance. To learn more about Modivcare, please visit www.modivcare.com. Contact Details Media Kate Zerone, Director, Ombudsman & Communications kate.zerone@modivcare.com Amendola Communications Kim Warth kwarth@acmarketingpr.com

March 30, 2022 09:30 AM Eastern Daylight Time

AngelEye Health Strengthens Senior Sales Team with Series of Strategic New Hires

AngelEye Health

AngelEye Health, a leading provider of family engagement solutions for hospital neonatal and pediatric intensive care units, today announced a move to expand its sales network with the addition of five account managers and one clinical sales associate, creating the company’s first internal sales team. Kent Meeks, Arturo Ruvalcaba, David Broad, Scott Duyck, Vicki Koch and Olivia McCracken each bring extensive healthcare industry experience having served in similar roles representing Natus NicView, Medela, and GE. Kent Meeks: (Account Manager for the Southeast). Previously served as a product sales specialist for Maternal-Infant Care at GE Healthcare. Arturo Ruvalcaba: (Account Manager, Texas, Oklahoma, Kanas, Missouri). As a territory manager at Medela, Arturo spent eight years focused squarely on product sales in support of the NICU environment. David Broad: (Account Manager for the Northeast). When a product specialist at Natus Medical Incorporated, David spearheaded NicView streaming camera system sales throughout the eastern half of the US. Scott Duyck: (Account Manager for the West coast). Scott has worked in neonatal product sales for over 12 years, first at Natus Medical, selling products including hearing screening products, phototherapy lights, and brain monitors and at Medela selling feeding-related solutions. Vicki Koch: (Account Manager for the Midwest). Formerly a Midwest regional sales manager at Medela, Vicki brings to the position a deep appreciation for the care and compassion found in the NICU and a deep knowledge for complex hospital selling. Olivia McCracken: (Clinical Sales Associate, Florida). Olivia is a Registered Nurse with extensive experience working in the NICU and conducting clinical research. This new investment in the AngelEye Health sales team comes as the organization looks to grow its health system relationships and arm more hospital partners with innovative family engagement solutions. Today, AngelEye’s platform hosts four solutions each designed to elevate the parent/patient experience. The platform includes: The company's innovative CameraSystem™ which brings live-streaming video of the patient to family members anywhere, anytime, on any device. OnlineEducation™, a parental portal where hospitals can upload customizable education resources and monitor parents' progress on the patient's path to discharge. PatientConnect™, providing a secure one-way communication channel from the care team to family to easily share patient status and memorable moments. MilkTracker, an end-to-end feeding and milk inventory management solution. In 2022, AngelEye Health intends to continue to strengthen efforts to bring on more hospital partners that already have engagement solutions in place and are aware of the benefits of integrating tele-engagement capabilities into the NICU, but that are looking for a more comprehensive technology offering coupled with an exceptional level of customer service. "This is an exciting time for AngelEye Health as we look to strategically grow our hospital and health system relationships, and as such, extend our ability to have an even greater impact on the patients/families and care teams who rely on our solutions to enhance communication and care collaboration in NICUs and pediatric units," said Christopher Rand, CEO of Angel Eye Health. "With these recent account manager appointments, we are reinforcing our commitment to building the right team with the right level of healthcare industry experiences to help make our aggressive growth goals a reality in 2022." About AngelEye Health AngelEye Health has a deep understanding of the value that both family engagement and family-centered care bring to the neonatal and pediatric intensive care environment. We provide a complete HIPAA-compliant tele-engagement platform to integrate parents simply and seamlessly into the child's care team. Our approach has a proven, positive impact on the quality of the family experience, care delivery workflows for the dedicated bedside team, and patient outcomes. From admission to discharge, AngelEye positively impacts staff, families, and patients along the journey and ultimately to a successful transition home. From bonding, patient progress and treatment communication, feeding, and focused education, AngelEye offers a portfolio of solutions for supporting the highly specialized needs of the NICU and PICU today and of the future. www.angeleyehealth.com Contact Details Jessy Green +1 917-689-9295 jessy.green@svmpr.com Company Website https://www.angeleyehealth.com/

March 29, 2022 10:00 AM Eastern Daylight Time

Industrial Defender and GrayMatter Team Up to Equip Energy and Water Companies with Holistic Cybersecurity Defenses

Industrial Defender

Industrial Defender, the leader in operational technology (OT) security and GrayMatter, the top digital transformation services firm for industrial companies, announced today that they are teaming up to offer comprehensive cybersecurity solutions for critical infrastructure. Industrial organizations seek out GrayMatter to assess their OT cybersecurity needs and curate the best technologies available, and the Industrial Defender platform is now an essential part of their technology offerings. GrayMatter's deep experience in the manufacturing, utility and water/wastewater industries complements Industrial Defender's focus on providing the foundational cybersecurity controls that protect critical infrastructure. Industrial Defender and GrayMatter follow a five-part approach to strengthening cybersecurity based on the NIST Cybersecurity Framework (CSF), and they both understand that operational technology environments demand unique cybersecurity solutions. “Partnering with GrayMatter is a huge win for critical infrastructure companies,” said Jim Crowley, CEO of Industrial Defender, “GrayMatter’s deep market knowledge and digital transformation expertise, combined with our cutting-edge OT data collection and normalization software provides them with the people, process and technology to build the strongest cybersecurity defenses possible.” "We're excited to partner with Industrial Defender," says GrayMatter Co-Founder and CEO James Gillespie, "Like us, they've been helping companies strengthen their OT cybersecurity for years, and they specialize in energy, water/wastewater and other critical industries that have made it a priority to stay ahead of new vulnerabilities and regulations." The Industrial Defender platform empowers organizations to turn cybersecurity data into action by safely collecting, monitoring, and managing OT endpoint and network data at scale. With just a few clicks, Industrial Defender also provides the necessary data to measure a security program against many different standards, including the NIST CSF. To learn more about this partnership, contact Industrial Defender at www.industrialdefender.com or GrayMatter at www.graymattersystems.com. About Industrial Defender Since 2006, Industrial Defender has been solving the challenge of safely collecting, monitoring, and managing OT asset data at scale, while providing cross-functional teams with a unified view of security. Their specialized solution is tailored to complex industrial control system environments by engineers with decades of hands-on OT experience. Easy integrations into the broader security and enterprise ecosystem empower IT teams with the same visibility, access, and situational awareness that they’re accustomed to on corporate networks. Learn more at www.industrialdefender.com. About GrayMatter GrayMatter’s goal is to transform operations and empower people. Since 1991, we have been helping some of the biggest industrial organizations in the world harness data so they can work smarter. They lean on us to secure their critical systems and connect their industrial assets to their teams so that every operator is empowered to be the best operator. GrayMatter has been on the Inc. 5000 fastest-growing companies list for six consecutive years and has grown to provide Advanced Industrial Analytics, OT Cybersecurity, Digital Transformation and Automation & Control services to clients in CPG, energy, food & beverage, manufacturing and water/wastewater industries across the U.S. and Canada. Learn more at graymattersystems.com. Contact Details Industrial Defender Erin Anderson +1 617-675-4206 eanderson@industrialdefender.com Company Website https://www.industrialdefender.com

March 29, 2022 09:00 AM Eastern Daylight Time

UNOS Receives Over $800,000 in Grant to Support Organ Tracking Tech

United Network for Organ Sharing

S.L. Gimbel Foundation, a component fund at the Inland Empire Community Foundation, recently awarded United Network for Organ Sharing (UNOS) an $836,208 grant to support two innovative tools: the UNOS Organ Tracking Service and the UNOS Travel App. UNOS is the engine that powers the national organ donation and transplantation system. “UNOS continues to harness the power of modern technology and meaningful collaborations to ensure that lifesaving donor organs continue to get where they need to go,” UNOS CEO Brian Shepard said. “Both the tracking service and the travel app are the most recent examples of how we’re working to provide donor families, recipient families, patients and medical professionals with the peace of mind they need, and I am proud that our team continues to develop evidence-based, tech-driven solutions that save even more lives.” "The S.L. Gimbel Foundation Fund is proud to support the important work of UNOS and the innovative tools they're using to help organ donors and recipients across the country," said Celia Cudiamat, SVP of Grants and Community Impact at IECF. "It is a great privilege to disperse these funds on their behalf, knowing their desire to focus on human dignity issues as a priority in their giving." UNOS Organ Tracking Service Developed by UNOS and tested by organ procurement organizations (OPOs) across the country, the service is now in use by 13 of the nation’s 57 OPOs. With this service, OPOs and transplant hospitals know when an organ is in transit, when it arrives at an airport, when the flight departs, and when the organ has arrived at its destination, all in real time. The grant will fund the continued expansion of the tracking service, providing upgraded technology, a suite of advanced notifications including travel predictions, and other improvements. This will provide OPOs with an even more reliable, user-friendly way to track organs in transit. UNOS Travel App Select OPOs began piloting the UNOS Travel App in late 2020. The tool helps OPOs make more informed transportation plans by providing them with a view of all available options, including flight schedules, driving directions, travel times and other useful information. The grant will pave the way for the full deployment of the UNOS Travel App, making it possible to integrate this service into the current organ offer system, assisting both OPOs and transplant hospitals with logistical decisions. This generous grant comes after a year of historic firsts for UNOS and the entire donation and transplant community, including surpassing 41,000 transplants in a single year for the first time in 2021, as well as record-breaking numbers of kidney, heart, and liver transplants. ### About United Network for Organ Sharing United Network for Organ Sharing (UNOS) is the mission-driven non-profit serving as the nation’s transplant system under contract with the federal government. We lead the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to honoring the gifts of life entrusted to us and to making lifesaving transplants possible for patients in need. Working together, we leverage data and advances in science and technology to continuously strengthen the system, increase the number of organs recovered and the number of transplants performed, and ensure patients across the nation have equitable access to transplant.. About the Inland Empire Community Foundation Founded in 1941, the Inland Empire Community Foundation is the oldest and largest community foundation in Inland Southern California. We partner with individuals, families and corporations to help them achieve their charitable goals. Since inception, we have given out over $124 million in grants and scholarships. For more information visit the IECF’s website at www.iegives.org. Be a part of our conversation on Facebook, Twitter and LinkedIn. Contact Details Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

March 25, 2022 04:06 PM Eastern Daylight Time

AngelEye Health Obtains ISO 9001:2015 Certification for Quality Management

AngelEye Health

AngelEye Health, a leading provider of family engagement solutions for hospital neonatal and pediatric intensive care units, today announced that it has maintained the ISO 9001:2015 Certification for Quality Management Systems (QMS). This continued validation helps cement its reputation as a quality-first organization, generating additional credibility with hospital partners around the country. ISO 9001:2015 is a globally recognized quality standard developed and published by the International Organization for Standardization (ISO). Organizations globally use the standard to demonstrate to their customers that they can provide consistent products and services. The standard is based on several quality management principles, including AngelEye’s strong customer focus, the involvement of the organizations' upper management and leadership structures, an outlined, process-based approach, and ongoing improvement of the quality management system. To earn the ISO 9001:2015-certification, AngelEye underwent and passed a rigorous third-party audit. As a family engagement solutions provider, this accreditation demonstrates that management has done its due diligence in continuously providing products and services that meet customer and applicable statutory and regulatory requirements. The company’s ISO 9001:2015 certificate was issued by DEKRA, an organization globally renowned for over a century in the testing, inspection, and certification of quality management standards. "The ISO QMS certification provides the industry with an objective standard on the definition of quality. We are so proud that the AngelEye Health name will now be synonymous with consistency in products and services that not only meet but exceed what our hospital partners are looking for in a family engagement solution provider,” said David Landman AngelEye Health’s chief commercial officer. “As a customer focused organization, we are always looking for ways to better support our current and future clients. We believe that this ISO 9001:2015 certification will go a long way to support our team’s efforts to continuously improve our approach to quality management.” About AngelEye Health AngelEye Health has a deep understanding of the value that both family engagement and family-centered care bring to the neonatal and pediatric intensive care environment. We provide a complete HIPAA-compliant tele-engagement platform to integrate parents simply and seamlessly into the child's care team. Our approach has a proven, positive impact on the quality of the family experience, care delivery workflows for the dedicated bedside team, and patient outcomes. From admission to discharge, AngelEye positively impacts staff, families, and patients along the journey and ultimately to a successful transition home. From bonding, patient progress and treatment communication, feeding, and focused education, AngelEye offers a portfolio of solutions for supporting the highly specialized needs of the NICU and PICU today and of the future. www.angeleye.health Contact Details SVM PR & Marketing Jessy Green +1 917-689-9295 jessy.green@svmpr.com Company Website https://angeleye.health/

March 24, 2022 10:00 AM Eastern Daylight Time

VinFuture foundation announces 2022 VinFuture webinar series for nominators

Vingroup

HANOI, VIETNAM – Media OutReach – 24 March 2022 - As part of the sequence of activities for the second VinFuture Prize season, VinFuture Foundation has officially launched a series of six webinars in six different time zones around the world. This series of events aims to provide information directly to scientists across the globe and attract the most outstanding nominations to promote post-COVID-19 reconstruction and sustainable development. The webinar series will take place via Zoom from March 23 to April 19, 2022 and will be tailored for distinct geographic regions and time zones, including: US East and West Coasts, Europe, Africa, Asia, and Oceania. The webinars will be led by members of the VinFuture Prize Council and Pre-screening Committee and will feature the prize laureates from the first season. The second VinFuture Prize season, themed "Reshaping and Reviving", is focused on inventions and scientific initiatives accelerating the world's reconstruction and sustainable development following the COVID-19 pandemic. Since its official launch on February 16, 2022, the second season has received immense support from the global scientific community, with more than 1,000 organizations and individuals from 81 countries participating as nominators for the prize. To date, the scientific community in Asia has contributed the highest number of nominators with 34% of the total share, followed closely by the Americas with 33%, Europe with 22%, Australia with 6%, and Africa with 5%. The webinar series aims to provide the latest information directly to scientists worldwide and promote diversity and breadth in all potential areas. Through this series, VinFuture will address inquiries and concerns about the nomination process as well as share practical and inspirational perspectives from members of the Pre-screening Committee, the Prize Council, and especially the first season’s laureates. VinFuture Prize is an annual international award for breakthrough scientific and technological inventions that have created, or have the potential to create, meaningful changes in people's lives. Despite being a new award, with the mission of serving humanity and a selection process with high integrity and transparency, VinFuture has already built a strong reputation in the global scientific community. In the first season, VinFuture received nearly 1,200 nomination submissions from six continents around the world just four months after officially launching the nomination portal. VinFuture's nominators include institutes of higher education such as Harvard University, Cambridge University, Oxford University, and University of Tokyo, and prestigious organizations such as the National Institutes of Health of the United States, The Max Planck Society of Germany, Chinese Academy of Sciences, and more. The laureates of the first VinFuture Prize season are truly outstanding scientists that have been honored worldwide for their scientific achievements for humanity. The Grand Prize, with a value of US$3 million, was awarded to three prominent scientists: Dr. Katalin Karikó, Prof. Drew Weissman (USA) and Prof. Pieter Cullis (Canada) for the development of mRNA technology, paving the way for the production of effective vaccines to help prevent COVID-19 outbreaks, as well as potential vaccines for HIV, cancer, autoimmune and genetic diseases, helping to protect the future health of millions of people in the world. 2022 nomination portal: https://online.vinfutureprize.org/nomination For more details about the Prize: Detailed instructions about the nomination process and nomination form: https://online.vinfutureprize.org/nomination FAQs: https://vinfutureprize.org/faqs/ Information about the first VinFuture Prize: https://vinfutureprize.org/laureates/ * Webinar Series Agenda: About the VinFuture Foundation The VinFuture Foundation, established on December 20th, 2020, on the occasion of International Human Solidarity Day, is an independent, not-for-profit foundation established by billionaire Mr. Phạm Nhật Vượng, and his wife, Madam Phạm Thu Hương. The vision and mission of the Foundation is to create positive changes in the lives of millions of people in the world. The core activity of the Foundation is awarding the annual VinFuture Prizes to breakthrough scientific research and technological innovations that have already contributed or have the potential to contribute to the betterment of life for people. The VinFuture Prize consists of four prize categories, of which the Grand Prize – with a value of US$3 million – is one of the largest annual global prizes, and three additional Special Prizes, worth US$500,000 each, are dedicated to Female Innovator(s), Innovator(s) from Developing Country(ies), and Innovator(s) with Outstanding Achievements in Emerging Fields. In addition, the Foundation also conducts many activities to realize its mission, such as funding research, collaborating in academic development, and promoting STEM education. 2021 VinFuture Prize Laureates The Grand Prize: Dr. Katalin Karikó, Prof. Drew Weissman (USA) and Prof. Pieter Cullis (Canada) with their breakthrough research on mRNA technology for vaccines. Special Prize for “Innovators with Outstanding Achievements in Emerging Fields”: Professor Omar Yaghi (USA) with his work on discovering metal-organic frameworks (MOFs)' Special Prize for “Female Innovators”: Professor Zhenan Bao (USA) with her work on developing flexible electronics with the sensing properties of human skin. Special Prize for “Innovators from Developing Countries”: Prof. Salim S. Abdool Karim and Professor Quarraisha Abdool Karim (South Africa), for their Research on Pre-Exposure Prophylaxis with Antibiotics virus. Contact Details Vingroup v.nammh@vingroup.net Company Website https://vinfutureprize.org/

March 24, 2022 09:30 AM Eastern Daylight Time

Image

Lawsuit Challenging Nation’s Kidney Allocation Policy Is Dismissed

United Network for Organ Sharing

A lawsuit against United Network for Organ Sharing (UNOS) and the U.S. Department of Health and Human Services (HHS) challenging the nation’s current kidney allocation policy was dismissed on March 22 when plaintiffs withdrew their challenge, according to the District Court for the Southern District of Iowa. This follows a ruling in November of 2021 when the 8 th Circuit Court of Appeals ruled that the same plaintiffs were not likely to win on the merits of the case they presented. The kidney policy went into effect in March of last year. “The current kidney allocation policy is the result of respectful debate and discussion that included voices from across the donation and transplantation community,” said UNOS CEO Brian Shepard. “The numbers show that this policy is working as intended, and we thank our many dedicated OPTN volunteers, who donated their time to make our high-performing system even better.” Recent data shows kidney transplants for all populations have increased following the implementation of the policy, including a 22% increase in kidney transplants nationwide. UNOS will continue to monitor key metrics of the policy's performance to ensure that it continues as expected and to identify any areas for further development. “These numbers not only prove that the policy is increasing equity, but that the process that got us here was both effective and fair,” said UNOS Board President Matthew Cooper, M.D. “As we see the policy’s very real impact on the lives of kidney waitlist candidates and recipients, all of the patients, donor families, volunteers and others involved in developing this policy should be proud of what they have accomplished.” About UNOS United Network for Organ Sharing (UNOS) is a non-profit, charitable organization that serves as the Organ Procurement and Transplantation Network (OPTN) under contract with the federal government. The OPTN helps create and define organ allocation and distribution policies that make the best use of donated organs. This process involves continuously evaluating new advances and discoveries so policies can be adapted to best serve patients waiting for transplants. All transplant programs and organ procurement organizations throughout the country are OPTN members and are obligated to follow the policies the OPTN creates for allocating organs. Contact Details Anne Paschke +1 804-782-4730 anne.paschke@unos.org Company Website https://unos.org

March 23, 2022 06:20 PM Eastern Daylight Time

Going Back to Work: Who Will You Miss More? Your Family or Your Dog?

YourUpdateTV

With more people returning to the office, there’s a lot of anxiety and stress around what to do with four-legged family members who have become accustomed to having their pet parents at home. Recently, international dog trainer, Tom Davis, partnered with Wag! on a satellite media tour to talk about the type of care and training required to keep our pets happy. A video accompanying this announcement is available at: https://youtu.be/noALR-no8ig Over the past 2 years, many people adopted puppies and dogs during the pandemic. Right now, and over the next few weeks, millions of people will be returning to offices and workplaces for the first time. This transition period raises several issues for dogs: increased stress and anxiety, as well as lack of exercise and social play. In honor of National Puppy Day (March 23rd), Wag! conducted a national survey* and found that out of the 1,001 respondents, 62% percent have adopted a dog in the last two years during the pandemic. 41% of those dog parents returning to work said that they’ll miss their dogs even more than their kids or spouses. Out of those new dog parents, 76% are nervous about pet care challenges upon returning to work in- person. Some other key highlights include: Dogs are the best medicine: 93% say parenting a dog has provided them mental health support, while 48% say that dog parenting has decreased their anxiety. Puppy love is real: 37% say that the most surprising thing about parenting a new puppy was the overwhelming amount of love for their new friend Pet insurance is the single biggest challenge for new dog parents: 63% of respondents expressed surprise at how much time, effort and money was required for pet insurance, more than any other challenge of becoming a new pet parent. Dogs and parents can both suffer behavioral issues/anxiety being separated from each other. Services like Wag!, which connects Pet Parents with local Pet Caregivers for dog walking and longer drop-ins for play time, can give your dog the much-needed stimulation, and peace-of-mind for pet parents. Like human health insurance, it’s important to also get insurance for our pets. Pets are our family, and their health is just as important. WagWalking.com is a great resource for more information on pet insurance and wellness. For more information on the survey and Wag! check out WagWalking.com About Tom Davis: Tom Davis is an international dog trainer who specializes in dog training based on canine behavior, and he is known for taking in some of the hardest behavior modification training cases. His natural ability to understand and connect with dogs allows him to breakthrough problems, such as reactivity and disobedience. Tom knows that educating people about their dogs, and changing negative behaviors, is what he was put on this Earth to do. Tom spends the first several hours of his weekdays with his online dog training students, who are located across the United States and all over the world. Several times per month, Tom boards a plane to work with out-of-state clients, including professional athletes, musicians, actors and politicians. And most of his summers are spent studying with wolves in Colorado, allowing him to understand the canine with full complexity. Tom is also an official mentor trainer for the Animal Behavioral College, where his responsibilities include fine-tuning and mentoring graduating seniors. He plays a critical role in ensuring each student has the capability and canine skills to successfully graduate and enter into their professional career. About Wag!: Wag! is the #1 app for pet parents, offering options for 5-star dog walking, pet sitting, expert pet advice, and training from local pet caregivers nationwide. Wag!'s community of 400,000 pet caregivers are pet people, and it shows. Making pet parents happy is what Wag! does best. With safety and happiness at the forefront, pet caregivers with Wag! have a trusted record of experience with nearly 12 million pet care services across all 50 states, resulting in more than 96% of their reviews earning 5 stars. Survey Methodology Summary: * This sample of 1001 U.S. adults (18 years or older), all of whom are dog parents of at least one dog adopted, purchased or gifted to them within the past 2 years, was surveyed between February 14, 2022 and February 17, 2022. DKC Analytics conducted and analyzed this survey with a sample procured using the Pollfish survey delivery platform, which delivers online surveys globally through mobile apps and the mobile web along with the desktop web. No additional weighting has been applied to the sample. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

March 23, 2022 02:14 PM Eastern Daylight Time

Video

Psychedelic Pharmaceutical Startup Ninnion Announces Formation of World Renowned Scientific Advisory Board

Ninnion

Ninnion, a clinical-stage pharmaceutical company focused on developing next-generation psychedelic therapeutics today announced the formation of its Scientific Advisory Board (SAB). The board is composed of key opinion leaders in pharmaceutical development and psychedelics research, including Rick Strassman, MD, Charles B Nemeroff, MD, and chaired by Bill W. Massey, PhD, Ninnion’s Chief Development Officer. “The level of experience and expertise embodied in our Scientific Advisory Board is absolutely world-class. The SAB members bring a great balance of scientific, drug development and clinical expertise to Ninnion’s programs. Their guidance will be a tremendous asset in navigating the uncharted waters of psychedelic drug development,” said Bill W Massey, Chief Development Officer of Ninnion. The new SAB is composed of world renowned leaders in the areas of psychedelic research and drug development from top-tier organizations including Johns Hopkins, the Karolinska Institute and University of Texas, Austin. The SAB will work closely with Ninnion leadership, assisting with scientific judgments related to research and pipeline development. “I’m delighted to serve as a member of Ninnion’s Scientific Advisory Board - this is an opportunity to work together with the best minds in the psychedelic pharmaceutical industry during a time of significant growth and discovery. Collectively we will aim to guide Ninnion through the development of its current pipeline and are committed to following the science as we move forward in developing thoughtful, evidence-based solutions,” said Rick Strassman, MD. Ninnion’s research and development efforts currently focus on advancing second and third generation psychedelic therapies, which will ultimately empower patients with more accessible and affordable treatment opportunities. The SAB is an integral part of Ninnion’s vision to improve lives and forever change the landscape of today’s psychedelic pharmaceuticals. “I am honored to be surrounded by such great minds and key opinion leaders contributing to our Scientific Advisory Board. We are bringing the best minds together to create the next generation of psychedelic drug therapies to enhance the lives of patients, starting with those recovering from ischemic stroke.” said Jeremy Caudill, Founder and Chief Executive Officer of Ninnion. The founding members of the Ninnion Scientific Advisory Board are: Rick Strassman, MD, is a world renowned psychiatrist, psychopharmacologist, and pioneer in the advancement of clinical psychedelic research. After 20 years of intermission, Dr. Strassman was the first person in the United States to undertake human studies with psychedelic drugs, with his research on DMT and psilocybin in the early 1990s. Charles B. Nemeroff, MD, is an internationally recognized psychiatrist and researcher, specializing in the areas of Neuropsychopharmacology, Psychiatry, mood disorders, and trauma. He serves as the Matthew P. Nemeroff Professor and Chair of the Department of Psychiatry and Behavioral Sciences at the University of Texas at Austin Dell Medical School. Ede Frecska, MD, is a prolific author, researcher, and scholar with over 100 peer-reviewed papers and book chapters to his credit. He currently serves as Chief of Department at the National Institute of Psychiatry and Neurology in Budapest. Attila Szabo, Ph.D., is a distinguished scholar, researcher, and advocate in the areas of psychoneuroimmunology, immunopsychiatry, biological psychiatry, and the molecular biology of inflammation. His current research focuses on immune-brain interactions in severe mental disorders. Patrick Finan, Ph.D., is a trained clinical psychologist and expert in cognitive, behavioral, and affective non-pharmacological mechanisms and treatments for chronic pain. His research focuses on chronic pain and measurement and analysis of dynamic measures of pain and emotion captured in the course of daily life. Dr. Finan is currently the Principal Investigator or Co-Investigator on 8 NIH-funded grants totaling over $20 million. Brent Turnipseed, MD, is a dedicated mental health professional and entrepreneur whose work in behavioral health strives to elevate the standard of care for those living with severe mental illness. As a Medical Director and Co-founder of Roots Behavioral Health, Dr. Turnipseed focuses on providing affordable care and expanding access to emerging therapies like ketamine-assisted therapy (KAP) and psychedelic therapeutics. Mathias Egermark, MD, is a versatile and agile clinician and healthcare executive with a passion for building high-performing teams in clinical trials and development. Combining years of experience in clinical practice, pharmaceutical development, and business leadership, Dr. Egermark has distinguished himself as a leader in managing cross-functional teams in global settings. Jair Soares, MD, Ph.D., is a well-recognized researcher, academic, and clinician who has published over 300 peer-reviewed articles and book chapters in the field of psychiatry. He has been the recipient of numerous awards, academic and non-academic honors & appointments, including over two dozen awards for his work in the field of medicine and psychiatry. He is a board-certified psychiatrist and serves as Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at UTHealth Houston Medical School, and director for the Center of Excellence on Mood Disorders. To find out more about Ninnion’s Scientific Advisory Board and or to view a full list of its members, visit www.ninnion.com/. About Ninnion Headquartered in Austin, Texas, Ninnion is a pharmaceutical company on a mission to build a fully integrated pharmaceutical psychedelics eco-system leveraging the latest AI drug discovery, development, cGMP manufacturing, commercialization, patient clinics and specialty pharmacy distribution network designed for the next frontier of psychedelic medicine. Focused on the payer-reimbursed market, Ninnion has begun developing a pipeline of next generation psychedelic therapies with a clinical focus on brain injury, chronic pain, inflammation, and addiction disorders. To learn more, visit www.ninnion.com. Contact Details Jive PR + Digital Ashley Areeda +1 734-891-4013 aareeda@jiveprdigital.com

March 23, 2022 12:18 PM Eastern Daylight Time

1 ... 231 232 233 234 235 ... 306